Insider · CIK 0001024008
David S Kabakoff
Files at NXTC (NextCure, Inc.). First filing -, latest -.
In brief
David S Kabakoff files SEC Form 4 as director at NXTC (NextCure, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David S Kabakoff has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,510 | $0.00 | $0 | 3,510 | Jun 22, 2026 |
| Jun 20, 2025 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +28,050 | $0.00 | $0 | 28,050 | Jun 24, 2025 |
Questions about David S Kabakoff
Answered from the filings on this page, as of the latest one.
Is David S Kabakoff buying or selling?
David S Kabakoff has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David S Kabakoff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David S Kabakoff has 0.
Where does David S Kabakoff file Form 4?
David S Kabakoff has filed Form 4 at NXTC (NextCure, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.